
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Elligo Health Research has announced the acquisition of ClinEdge, which also includes GuideStar Research and BTC of New Bedford. The transaction of $135 million was funded through new co-lead investors Morgan Stanley Expansion Capital and Ally Bridge, along with participation from Norwest Venture Partners and existing investors.
Perella Weinberg Partners served as financial advisor and Goodwin Procter LLP served as legal counsel to Elligo. Edgemont Partners served as exclusive financial advisor to ClinEdge.






